Menaquinone‐4 Enhances Steroidogenesis in Testis Derived Tumor Cells Via the Elevation of cAMP Level

Naturally existing vitamin K consists of vitamins K1 and K2. Menaquinone‐4 (MK‐4), an analog of vitamin K2 and a product of vitamin K1 metabolism, can be detected in several organs, including the testis; however, the function of MK‐4 in these tissues has not been well characterized. Recent studies have suggested that vitamin K is involved in enhancing protein kinase A (PKA) activity in several cell types, thus regulating numerous PKA‐dependent biological processes. To highlight the effect of vitamin K, we focused on its role in the steroidogenic pathway. Experiments on vitamin K–deficient rats revealed a reduced expression of genes involved in the biosynthesis of cholesterol and steroid hormones in the testis. Moreover, compared with control animals, rats fed on MK‐4 diet presented significantly higher testosterone levels in the plasma and testis. These results suggest that vitamin K is involved in the steroidogenic pathway in the testis. Testosterone levels were found to increase in a dose‐dependent manner also in cell‐based experiments upon addition of MK‐4, but such an effect was not observed in vitamin K1 levels. Furthermore, the effect of MK‐4 on testosterone production was abolished by the specific PKA inhibitor H89, thus confirming the regulatory role of MK‐4 on PKA activation. Here, we describe how MK‐4 modulates PKA activation by enhancing intracellular 3′,5′‐cyclic adenosine monophosphate (cAMP) levels in testis‐derived I‐10 cells. The presented evidence supports the role of MK‐4 in cAMP/PKA signaling and steroidogenesis

Recent Topics in the Studies of Laboratory of Nutrition, Tohoku University : Newly Clarified Function of Vitamin K

Vitamin K (VK) is essential for blood coagulation and bone metabolism in mammals as a Gla-protein activating factor, i.e., VK acts as a cofactor in the posttranslational synthesis of γ-carboxyglutamic acid (Gla) from glutamic acid (Glu) residues in the nascent proteins. Menaquinone-4 (MK-4) is one of the VK_2 analogues, and is well known to have bioactivity in the suppression of bone resorption through apoptosis of osteoclast cells, thus MK-4 is now also used clinically as a therapeutic drug for the osteoporosis. Besides of these well-known functions, MK-4 is strongly presumed to have other novel functions because we have gradually recognized that MK-4 accumulates in various tissues of germfree animals fed an MK-4-free diet. Accordingly, we have focused on clarification of the mechanism of MK-4 formation in several tissues, using both in vitro tissue homogenates (bovine, rats, mice, chicken) and in vivo experiments with rats and mice. To elucidate the biological role of MK-4 production, we used germfree rats to eliminate MK-n synthesized by intestinal flora. Our in vivo results indicate that MK-4 is produced in diverse tissues from ingested vitamin K analogues, including vitamin K_1, MK-n (MK-6, MK-7, and MK-10); and VK_3 without enzymatic participation of microorganisms in the intestine. In addition to the liver and bone, VK is found in the brain, heart, testis, kidney, pancreas and salivary glands mainly as menaquinone-4 (MK-4). However, the physiological role of MK-4 in these various organs has not been fully understood yet. In the present study we identified genes of which expression is changed in testis under vitamin K deficient condition using DNA microarray. The genes involved in the biosynthesis pathway of cholesterol and steroid hormone were decreased in vitamin K deficient group. The amount of Cyp11a (P450scc) mRNA, rate-limiting enzyme for testosterone synthesis, was positively correlated with the concentration of MK-4 in testis. Moreover, the concentration of testosterone in plasma and testis was decreased in vitamin K deficient group compared with the control and vitamin K supplemented groups. These results suggests that vitamin K is involved in steroid production in testis through the regulation of Cyplla

Menaquinone-4 enhances testosterone production in rats and testis-derived tumor cells

<p>Abstract</p> <p>Background</p> <p>Vitamin K is essential for the posttranslational modification of various Gla proteins. Although it is widespread in several organs, including the testis, the function of vitamin K in these organs is not well characterized. In this study, we investigated the function of vitamin K in the testis and analyzed its role in steroidogenesis.</p> <p>Methods</p> <p>Eight-week-old male Wistar rats were fed a diet supplemented with menaquinone-4 (MK-4, 75 mg/kg diet), one of the predominant K₂vitamins present in the testis, for 5 weeks. <it>In vivo </it>testosterone levels of the rats' plasma and testes were measured by enzyme-linked immunosorbent assay, and <it>in vitro </it>testosterone levels of testis-derived tumor cells (I-10 cells) maintained in Ham's F-10 medium with 10% fetal bovine serum were measured following treatment with MK-4 (0 to 100 μM) at several time points. Testosterone and cellular protein levels were analyzed with respect to their effects on steroidogenesis.</p> <p>Results</p> <p>Testosterone levels in the plasma and testes of MK-4-fed rats were significantly increased compared to those of control rats, with no obvious differences in plasma luteinizing hormone levels. Secreted testosterone levels from I-10 cells were elevated by MK-4, but not by vitamin K₁, in a dose-dependent manner independent of cAMP treatment. Western blot analysis revealed that expression of CYP11A, the rate-limiting enzyme in steroidogenesis, and phosphorylation levels of protein kinase A (PKA) and the cAMP response element-binding protein were all stimulated by the presence of MK-4. Enhancement of testosterone production was inhibited by H89, a specific inhibitor of PKA, but not by warfarin, an inhibitor of γ-glutamylcarboxylation.</p> <p>Conclusions</p> <p>MK-4 stimulates testosterone production in rats and testis-derived tumor cells via activation of PKA. MK-4 may be involved in steroidogenesis in the testis, and its supplementation could reverse the downregulation of testosterone production in elders.</p

The Role of Vitamin K in Cholestatic Liver Disease

Vitamin K (VK) is a ligand of the pregnane X receptor (PXR), which plays a critical role in the detoxification of xenobiotics and metabolism of bile acids. VK1 may reduce the risk of death in patients with chronic liver failure. VK deficiency is associated with intrahepatic cholestasis, and is already being used as a drug for cholestasis-induced liver fibrosis in China. In Japan, to treat osteoporosis in patients with primary biliary cholangitis, VK2 formulations are prescribed, along with vitamin D3. Animal studies have revealed that after bile duct ligation-induced cholestasis, PXR knockout mice manifested more hepatic damage than wild-type mice. Ligand-mediated activation of PXR improves biochemical parameters. Rifampicin is a well-known human PXR ligand that has been used to treat intractable pruritus in severe cholestasis. In addition to its anti-cholestatic properties, PXR has anti-fibrotic and anti-inflammatory effects. However, because of the scarcity of animal studies, the mechanism of the effect of VK on cholestasis-related liver disease has not yet been revealed. Moreover, the application of VK in cholestasis-related diseases is controversial. Considering this background, the present review focuses on the effect of VK in cholestasis-related diseases, emphasizing its function as a modulator of PXR